Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Plos One|August 13, 2013
LT-IIb(T13I), a non-toxic type II heat-labile enterotoxin, augments the capacity of a ricin toxin subunit vaccine to evoke neutralizing antibodies and protective immunityChristopher J Greene, Chrystal M Chadwick, Lorrie M Mandell, et al.
Journal of Leukocyte Biology|April 10, 2016
Enhancement of humoral immunity by the type II heat-labile enterotoxin LT-IIb is dependent upon IL-6 and neutrophilsChristopher J Greene, John C Hu, David J Vance, et al.
Plos One|December 24, 2014
Intradermal administration of the Type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigenJohn C Hu, Camila Mathias-Santos, Christopher J Greene, et al.
International Journal of Molecular Sciences|December 28, 2018
LT-IIc, A Bacterial Type II Heat-Labile Enterotoxin, Induces Specific Lethality in Triple Negative Breast Cancer Cells by Modulation of Autophagy and Induction of Apoptosis and NecroptosisPatricia Masso-Welch, Sofia Girald Berlingeri, Natalie D King-Lyons, et al.
Infection and Immunity|March 23, 2016
Novel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal ColonizationChristopher J Greene, Laura R Marks, John C Hu, et al.
Infection and Immunity|September 24, 2005
Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tractFrederik W van Ginkel, Raymond J Jackson, Naoto Yoshino, et al.
Journal of Virology|February 27, 2009
Ganglioside-linked terminal sialic acid moieties on murine macrophages function as attachment receptors for murine norovirusesStefan Taube, Jeffrey W Perry, Kristen Yetming, et al.
Nature Communications|December 23, 2016
Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacyKristin L Griffiths, Mushtaq Ahmed, Shibali Das, et al.
The American Journal of Pathology|November 5, 2013
Mucosal pre-exposure to Th17-inducing adjuvants exacerbates pathology after influenza infectionRadha Gopal, Javier Rangel-Moreno, Beth A Fallert Junecko, et al.
The Journal of Antimicrobial Chemotherapy|September 17, 2016
High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumanniiJustin R Lenhard, Jürgen B Bulitta, Terry D Connell, et al.
Pageof 6